Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab

By sjmartinez • May 13, 2025

Kim GH, Zhang X, Brown MS, Poole L, Goldin J. Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab. BMJ Open. 2025 May 12;15(5):e094559. doi: 10.1136/bmjopen-2024-094559. PMID: 40355288.

Tags: Chest imaging, Computed tomography, interstitial lung disease, Patient reported outcome measures, Publications, Pulmonary Disease, Pulmonary, Critical Care & Sleep Medicine, QUALITATIVE RESEARCH

Computational frameworks for enhanced extracellular vesicle biomarker discovery

Kim J, Yang JD, Agopian VG, Zhu Y, Tseng HR, You S. Computational frameworks for enhanced extracellular vesicle biomarker discovery. Exp Mol Med. 2026 Jan[...]

A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes

Abel ED, Ahima RS, Anderson EJ, Berg DD, Berger JS, Das S, Feinberg MW, Fisher EA, Garshick MS, Giannarelli C, Goldberg IJ, Hamburg NM, Kim[...]

Minor Papillotomy for Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum: A Randomized Clinical Trial

Coté GA, Durkalski-Mauldin V, Fogel EL, Moffatt DC, Wang AY, Lara LF, Tarnasky PR, Buxbaum JL, Dai SC, Jonnalagadda S, Willingham FF, Ross A, Keswani[...]